Cambridge UK, September 3, 2014: Abcam plc, a global leader in the supply of innovative protein research tools and services, announced today it has launched an exclusive range of highly validated conjugated antibodies for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting.
Abcam’s conjugated antibodies enable scientists to easily perform multi-protein analysis. It is essential for scientists to study and image proteins in their multi-component state rather than individually, as research findings indicate that proteins rarely operate in isolation but function within multi-protein complexes.
The majority of the new antibodies are developed using Abcam’s RabMAb® technology, and are conjugated to Alexa Fluor® dyes, HRP, or biotin, combining high signal to noise ratios with high specificity. Each antibody has been produced and extensively validated by Abcam’s scientists. Performance data including images, references and customer reviews is provided with each product.
“Product quality is of critical importance to Abcam. We’re developing our in-house product ranges, focusing on high production standards and verifying quality through additional in-house and independent validation.”
- Matthew Roe, Head of Reagents, Abcam
Alexa Fluor® is a registered trademark of Life Technologies. Alexa Fluor® dye conjugates contain(s) technology licensed to Abcam by Life Technologies.